Program overview
Context
Indication: Biliary Tract Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: SciClone Pharmaceuticals
PT-112 is flagged as timeline staleness signal because public records show timeline staleness. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Biliary Tract Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: SciClone Pharmaceuticals
Registry: 3/5
Timeline: 3/5
Recruitment burden: 1/5
Results availability: 0/5
Program risk: 4/5
https://clinicaltrials.gov/study/NCT05357196
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT05357196 | Unknown Status Signal (UNKNOWN) | stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal | Low Signal | rare_population_signal |